Skip to content

My Evli online service will be upgraded on Thursday March 27, 2025 between 7.00 pm. and 9.00 pm. During this time, all online services will be unavailable. We apologize for any inconvenience.

Aspo - Q1 profitability remained high

Aspo’s Q1 results clearly topped estimates, however the previous full-year guidance is retained for now as much uncertainty persists around Telko’s H2.
  • Aspo Q1 revenue was EUR 160.4m vs the EUR 132.2m/135.6m Evli/consensus estimates.
  • EBIT landed at EUR 10.3m, compared to the EUR 8.0m/7.6m Evli/consensus estimates. There were a total of EUR -4.9m in items affecting comparability, and Aspo’s adjusted EBIT amounted to EUR 15.0m.
  • ESL’s revenue was EUR 56.8m vs our EUR 50.9m estimate, while EBIT was EUR 7.9m vs our EUR 7.5m estimate.
  • Telko’s top line amounted to EUR 75.9m, compared to our EUR 58.1m estimate. EBIT was EUR 4.0m vs our EUR 1.8m estimate. There were a total of EUR -4.6m in items affecting comparability, and adjusted EBIT was EUR 8.6m. Telko’s Q2 performance should remain strong, but the situation for H2 is unclear.
  • Leipurin revenue was EUR 27.7m, compared to our EUR 23.2m estimate, while EBIT came in at EUR -0.4m vs our EUR 0.1m estimate. Items affecting comparability amounted to EUR -1.1m, adjusted EBIT being EUR 0.7m.
  • Other operations cost EUR 2.5m, compared to our EUR 1.4m estimate, including e.g. EUR 0.5m in extraordinary compensation to the former CEO.
  • Aspo retains its guidance and expects FY ‘22 EBIT in the EUR 27-34m range.
Open Report